Tick-Borne Encephalitis Vaccine (TICOVAC)

Tick-borne encephalitis (TBE) is a viral infection that affects the central nervous system, transmitted to humans through the bite of an infected tick. Symptoms include flu-like illness, fever, headache, nausea, muscle pain, and general discomfort.

TBE is predominantly found in Central and Eastern Europe, including countries like Poland, Romania, Lithuania, parts of Scandinavia, and across Russia.

Vaccination is recommended to reduce the risk of contracting TBE. Travellers may receive a vaccination course consisting of three doses: two doses given 1–3 months apart, with a third dose administered 5–12 months later as a booster. For accelerated protection, the second dose can be administered 14 days after the first.

Please note that the content of this website provides general health information and advice. It is not intended to diagnose, treat, prescribe, or substitute for professional medical advice. Always seek the guidance of your physician or another qualified healthcare provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay seeking it because of something you have read on this website. The owners and authors of this website do not accept any responsibility for your health or any medical outcomes resulting from your use of the information contained herein. Use the information provided at your own risk.